| Financial Year |
March 31 2023 |
| Monetary Funds |
208,821,292.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
279,095,308.39 |
| Advances to Suppliers |
7,503,398.44 |
| Other Receivables |
8,490,672.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,410,956.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,685,715.15 |
| Total Current Assets |
1,020,980,603.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
40,254,425.06 |
| Investment Properties |
-- |
| Fixed Assetes |
988,533,490.27 |
| Under-construction Projects |
1,343,064.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,448,106.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,092,506.00 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
18,971,600.00 |
| Sub-Total of Non-Current Assets |
1,166,206,888.08 |
| Total Assets |
2,187,187,491.46 |
| Short-Term Loans |
597,393,495.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
123,111,231.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,243,611.24 |
| Taxes Payable |
4,124,625.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,320,774.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
5,758,022.53 |
| Sub-Total of Current Liabilities |
754,555,809.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,380,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,442,617.25 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,822,617.25 |
| Total Liabilities |
777,378,426.43 |
| Paid-In Capital(Or Share Stock) |
351,300,000.00 |
| Capital Surplus |
830,314,866.51 |
| Surplus Reserve |
84,430,695.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
143,763,503.38 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,409,809,065.03 |
| Owner's Equity（Stockholder's Equity） |
1,409,809,065.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,187,187,491.46 |
